Rajesh K. Malik

Direttore Tecnico/Scientifico/R&S presso G1 THERAPEUTICS, INC.

Patrimonio netto: 259 824 $ in data 30/04/2024

65 anni

Health Technology

Consumer Services

Posizioni attive di Rajesh K. Malik

Società	Posizione	Inizio	Fine
G1 THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	01/07/2014	-
Meryx, Inc. Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.	Direttore/Membro del Consiglio	01/05/2018	-

Società	Posizione	Inizio	Fine
POIT BIOP	Direttore/Membro del Consiglio	30/06/2021	27/12/2023
POIT BIOP	Independent Dir/Board Member	30/06/2021	27/12/2023
AGENNIX AG	Direttore/Membro del Consiglio	01/01/2007	01/01/2013
AGENNIX AG	Direttore Tecnico/Scientifico/R&S	01/01/2007	01/01/2013
FENNEC PHARMACEUTICALS INC.	Direttore Tecnico/Scientifico/R&S	01/09/2004	01/01/2007
EMD Pharmaceuticals, Inc. EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski.	Direttore/Membro del Consiglio	01/01/2002	01/01/2004
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/01/2000	01/01/2002
University of Virginia	Corporate Officer/Principal	-	-
Agennix, Inc. Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX.	Direttore Tecnico/Scientifico/R&S	01/01/2007	-

University of Sheffield Medical School

Doctorate Degree

Distribuzione geografica

Posizioni

Chief Tech/Sci/R&D Officer	4
Director/Board Member	4
Corporate Officer/Principal	2

Settori

Health Technology	9
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	4
FENNEC PHARMACEUTICALS INC.	Health Technology
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
G1 THERAPEUTICS, INC.	Health Technology
POIT BIOP	Health Technology

Aziende private	4
Agennix, Inc. Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX.	Health Technology
EMD Pharmaceuticals, Inc. EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski.	Health Technology
Agennix AG Agennix AG BiotechnologyHealth Technology Agennix AG was a pharmaceutical company, which engaged in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs included oral talactoferrin alfa and RGB-286638. The company was founded in 1993 and was headquartered in Heidelberg, Germany.	Health Technology
Meryx, Inc. Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.	Health Technology